DaVita Market Cap 2010-2025 | DVA

DaVita market cap history and chart from 2010 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. DaVita market cap as of June 10, 2025 is $10.5B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $10.503B $12.816B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.809B 19.52
Encompass Health (EHC) United States $12.018B 25.48
Chemed (CHE) United States $8.102B 25.46
Elanco Animal Health (ELAN) United States $7.102B 15.21
Option Care Health (OPCH) United States $5.264B 23.47
RadNet (RDNT) United States $4.449B 282.33
Amedisys (AMED) United States $3.178B 21.38
LifeStance Health (LFST) United States $2.224B 0.00
Addus HomeCare (ADUS) United States $2.171B 23.84
Astrana Health (ASTH) United States $1.487B 36.85
U.S Physical Therapy (USPH) United States $1.200B 30.98
Aveanna Healthcare Holdings (AVAH) United States $1.061B 60.44
Pennant (PNTG) United States $0.977B 35.89
Atai Life Sciences (ATAI) Germany $0.451B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.046B 0.00
Daxor (DXR) United States $0.045B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00